T

Turnstone Biologics

108 employees

Turnstone Biologics is a privately-held clinical stage biotech company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Oncolytic Virus
Immuno-Oncology
Innovation Management
Cell Therapy
Cancer Immunotherapy
Immunotherapy
Therapeutics
Viral Immunotherapy
Cancer Research
TIL Therapy
Cancer

Date founded

2015

Funding rounds raised

Total raised

$80M

from 15 investors over 15 rounds

T

Turnstone Biologics raised $80M on July 14, 2021

Investors: Partner Fund Management, Sectoral Asset Management, Takeda UK Limited, OrbiMed Advisors, Ridgeback Capital Management LLC, Point72 Asset Management, Teralys Capital, Surveyor Capital, Versant Ventures and Sixty Degree Capital

T

Turnstone Biologics raised undisclosed on January 7, 2019

Investors: Sixty Degree Capital

T

Turnstone Biologics raised $41M on November 2, 2016

Investors: F-Prime Capital Partners, OrbiMed Advisors and Versant Ventures

T

Turnstone Biologics raised $11M on October 27, 2015

Investors: Versant Ventures

FAQ